Clinical Trials Directory

Trials / Completed

CompletedNCT05373459

Effect of a Third COVID-19 Booster Among Health Care Workers

Effect of a Third COVID-19 Booster on COVID-19 Infection Rate and Return to Works During Fifth Wave COVID-19 Among Health Care Workers

Status
Completed
Phase
Study type
Observational
Enrollment
3,167 (actual)
Sponsor
Hong Kong Sanatorium & Hospital · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

A new wave of COVID-19 infections, mainly caused by the Omicron/ Delta variant, has been sweeping the globe since the start of 2022. In response, the administration of a third dose of COVID-19 vaccine was considered to address potential waning immunity over time and reduced effectiveness against the Omicron/ Delta variant. The pandemic also resulted in many infections among health care workers (HCWs) and their households. In this study, a retrospective analysis would perform on risk of COVID-19 infection and their outcome in relation to their COVID-19 vaccination history by using the data repository from one of the Hong Kong private hospitals. HCWs were required to submit a standardized online self-declaration form for report of 1) demographic of the HCWs, 2) symptoms related history and 3) COVID-19 exposure history once they were COVID-19 confirmed by rapid antigen test against COVID-19 and/or polymerase chain reaction (PCR) test for COVID-19. Subsequent follow up such as contact tracing, COVID-19 PCR testing results of these HCWs and status of return to work were captured by the infection control team in a systematic manner.

Conditions

Interventions

TypeNameDescription
BIOLOGICALThird COVID-19 boosterThird COVID-19 booster

Timeline

Start date
2022-05-16
Primary completion
2022-12-31
Completion
2022-12-31
First posted
2022-05-13
Last updated
2024-02-28

Locations

1 site across 1 country: Hong Kong

Source: ClinicalTrials.gov record NCT05373459. Inclusion in this directory is not an endorsement.